Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Isoproterenol's Effects on Afterload and Cardiac Performance

Mechanism of Action and Clinical Evidence

  • Isoproterenol increases myocardial oxygen demand through positive chronotropic and inotropic effects while simultaneously decreasing coronary perfusion due to beta-2 mediated effects, as noted by the American College of Cardiology 1
  • The European Society of Cardiology guidelines state that isoproterenol produces pulmonary artery vasodilation but its use is severely limited by tachycardia and systemic vasodilation, and it is not recommended for use in hypotensive states where peripheral vasoconstriction is needed 2

Contraindications and Warning

  • Isoproterenol should not be relied upon as primary therapy to reverse myocardial dysfunction when used to treat alpha-agonist induced hypertension, as warned by the American Society of Anesthesiologists 3
  • The use of isoproterenol is contraindicated in settings requiring afterload support, as it will worsen hypotension, and in patients on VA-ECMO where excessive afterload reduction can worsen left ventricular distension, as noted by the Society of Critical Care Medicine 4